AirSculpt Technologies, Inc. Common Stock (AIRS) Stock Price

AIRSStock

$2.67−59.38%52W

Market Cap$192.49M

P/E—

PEG Ratio—

Div yield—

Beta2.35

AIRS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)28.44%

Price vs S&P 500 (4W)-46.40%

VGM Score23.62

P/CF (Annual)78.71x

Book Value / Share (Quarterly)$1.42

P/TBV (Annual)2.43x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-3.47%

Cash Flow / Share (Quarterly)$0.10

Price vs S&P 500 (YTD)21.37%

Gross Margin (TTM)66.06%

Net Profit Margin (TTM)-7.39%

EPS (TTM)$-0.18

10-Day Avg Trading Volume1.14M

EPS Excl Extra (TTM)$-0.18

Revenue Growth (5Y)19.31%

EPS (Annual)$-0.19

Dividend / Share (Annual)$0.00

ROI (Annual)-8.12%

Gross Margin (Annual)65.95%

Net Profit Margin (5Y Avg)-3.01%

Cash / Share (Quarterly)$0.24

Revenue Growth QoQ (YoY)0.05%

ROA (Last FY)-6.23%

Revenue Growth TTM (YoY)-11.78%

EBITD / Share (TTM)$0.01

ROE (5Y Avg)-7.33%

Operating Margin (TTM)-7.75%

Cash Flow / Share (Annual)$0.01

P/B Ratio2.43x

P/B Ratio (Quarterly)1.99x

Net Income / Employee (Annual)$-35,400

EV / Revenue (TTM)1.79x

Net Interest Coverage (TTM)-1.90x

ROA (TTM)-5.88%

EV / EBITDA (TTM)328.67x

EPS Incl Extra (Annual)$-0.19

Current Ratio (Annual)0.55x

Quick Ratio (Quarterly)0.57x

3-Month Avg Trading Volume0.91M

52-Week Price Return-59.38%

EV / Free Cash Flow (Annual)392.79x

Revenue / Employee (TTM)$460,100

Tangible BV / Share (Quarterly)$0.92

P/S Ratio (Annual)1.61x

Asset Turnover (Annual)0.81x

52-Week High$12.00

Operating Margin (5Y Avg)1.13%

EPS Excl Extra (Annual)$-0.19

CapEx CAGR (5Y)-8.21%

26-Week Price Return39.68%

Quick Ratio (Annual)0.36x

13-Week Price Return-49.81%

Total Debt / Equity (Annual)0.64x

Current Ratio (Quarterly)0.75x

Enterprise Value$271.81M

Revenue / Share Growth (5Y)17.33%

Asset Turnover (TTM)0.80x

Revenue / Employee (Annual)$460,100

Pretax Margin (Annual)-11.62%

Cash / Share (Annual)$0.13

3-Month Return Std Dev117.85%

Gross Margin (5Y Avg)65.99%

Net Income / Employee (TTM)$-34,000

EBITDA CAGR (5Y)-39.81%

EBITDA Interim CAGR (5Y)-23.02%

ROE (Last FY)-13.30%

Net Interest Coverage (Annual)-2.14x

EPS Basic Excl Extra (Annual)$-0.19

P/FCF (TTM)24.52x

EV / Free Cash Flow (TTM)39.14x

Total Debt / Equity (Quarterly)0.45x

EPS Incl Extra (TTM)$-0.18

ROI (TTM)-7.78%

P/S Ratio (TTM)1.60x

Pretax Margin (5Y Avg)-2.56%

Revenue / Share (Annual)$2.51

Tangible BV / Share (Annual)$0.79

Free OCF CAGR (5Y)-41.69%

Price vs S&P 500 (52W)-77.70%

Year-to-Date Return33.33%

5-Day Price Return-2.04%

EPS Normalized (Annual)$-0.19

ROA (5Y Avg)-2.82%

Net Profit Margin (Annual)-7.68%

Month-to-Date Return-45.11%

Cash Flow / Share (TTM)$0.05

EBITD / Share (Annual)$0.02

Operating Margin (Annual)-7.61%

LT Debt / Equity (Annual)0.58x

P/CF (TTM)32.50x

ROI (5Y Avg)-3.85%

LT Debt / Equity (Quarterly)0.39x

EPS Basic Excl Extra (TTM)$-0.18

P/TBV (Quarterly)3.09x

P/B Ratio (Annual)1.41x

Dividend / Share (TTM)$0.00

Pretax Margin (TTM)-11.38%

Book Value / Share (Annual)$1.36

Price vs S&P 500 (13W)-52.60%

Dividend Yield (TTM)0.00%

Beta2.35x

P/FCF (Annual)352.14x

Revenue / Share (TTM)$2.19

ROE (TTM)-12.42%

52-Week Low$1.51

vGradeD

gGradeD

mGradeD

vgmGradeD

AIRS Earnings Surprise History

Q2 250.02est. 0.01

Q3 25-0.15est. -0.03

Q4 25-0.02est. -0.02

Q1 26-0.01est. -0.02

Q2 260.01est. 0.02

AIRS Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

2.29

3.89

Industry Peers — Physicians' Offices(12)

Symbol	Value Score	Growth Score	Momentum Score	Price
AIRSAirSculpt Technologies, Inc. Common Stock	D	D	D	$2.67
HIMSHims & Hers Health, Inc.	D	C	B	$31.75
TDOCTeladoc Health, Inc.	A	C	D	$6.19
STLNStarling Oncology, Inc. Common Stock	—	—	B	$6.30
TOIThe Oncology Institute, Inc. Common Stock	D	A	A	$5.13
SBCSBC Medical Group Holdings Incorporated Common Stock	B	F	B	$4.25
AUNAAuna S.A.	A	D	C	$5.28
LFMDLifeMD, Inc. Common Stock	C	C	F	$3.25
CCMConcord Medical Services Holding Limited	B	A	C	$4.95
BMGLBasel Medical Group Ltd Ordinary Shares	A	A	F	$4.80
SBCWWSBC Medical Group Holdings Incorporated Warrants	—	—	A	$0.32
STLNWStarling Oncology, Inc. Warrant	—	—	B	$0.07
TOIIWThe Oncology Institute, Inc. Warrant	—	—	C	$0.05

About AirSculpt Technologies, Inc. Common Stock

AirSculpt Technologies Inc operates Elite Body Sculpture, a provider of premium minimally invasive body contouring procedures using its proprietary AirSculpt method. The company derives revenue exclusively from direct medical procedure services, offering custom fat removal to consumers seeking non-surgical body sculpting solutions.